Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-01

FDA Approved: ENSKYCE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for ENSKYCE (desogestrel and ethinyl estradiol), resulting in an approved change to the product und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENSEKYCE (Desogestrel and ethinyl estradiol)

Snippet

SUPPL AP for ENSKYCE (DESOGESTREL AND ETHINYL ESTRADIOL)